Don’t Wait for the Headlines. Be the Reason They’re Written.

This year marks ten years of Neopenda. A decade of building, fighting, dreaming, failing, iterating, and rising.

And if there’s one truth we’ve learned along the way, it’s this: We cannot do this alone.

We’re still here because of you, our community. From the earliest believers like Katie Reuther (forever grateful), to investors like Axel Johnson, Springhood, and Sorenson Impact Foundation, to the brilliant nurses and clinicians across Kenya, Uganda, and Ghana who co-create with us daily, community has always been at our core.

Especially now, in a world that often feels unstable and unjust, we believe more than ever in the power of collective action.

If you’re tired of watching the headlines roll in with more despair than hope, what’s better than investing in a company that’s proven it can do good and do well?

Why Community Rounds Matter (Even for VC-Backed Startups Like Ours)

There’s a shift happening. More and more startups, even VC-backed ones, are inviting their communities to invest.

It’s not a trend. It’s a transformation.

The traditional VC model wasn’t built for companies like ours. And to be clear, we’ve raised over $6 million, half of it from institutional investors, angel groups, and venture capital firms. We’ve been pushed, challenged, and supported by incredible funders who’ve helped us grow.

But here’s the reality: most VCs still don’t understand how to underwrite innovation in frontier markets, let alone medtech hardware for low-resource health systems in Africa. That’s not a critique, it’s a structural limitation.

We’re building what doesn’t exist yet.

There’s no roadmap. So we’re writing one.

We’re designing for markets that have been chronically underserved, not because they’re not viable, but because they’ve been misunderstood. Too complex. Too “different.” Too outside the box.

But just because something is less familiar doesn't mean it’s not valuable.

Just because a market is underexplored doesn’t mean it won’t deliver.

And just because investors haven’t taken the time to understand the African medtech landscape doesn’t mean it isn’t one of the most important and dynamic places to invest right now.

We’re playing the long game, and we’re already seeing it pay off.

That trust is being earned. That market is responding. The returns, human and financial, are very real. They just don’t fit neatly inside a 3-5 year exit timeline.

And that’s why community investment is so powerful.Because you’re not just betting on a financial model. You’re investing in people, in impact, and in persistence.You’re building a future with us, for returns, but also for a different kind of legacy.

Why Invest in Neopenda?

Because we’ve made it through the hardest part.

Because we’re scaling what works.

Because we’re building something the world actually needs.

• We’re ISO 13485 certified

• CE Mark approved

• Our flagship product, neoGuard, is commercially available

• We’ve built scalable manufacturing lines

• We’re selling directly to hospitals, and they’re buying, with their own budgets

  
  

More than 45 hospitals across Kenya, Uganda, and Ghana have purchased neoGuard, not because they were told to, but because they believe it’s essential.

This isn’t a charity project. This is a market demand.

We’re not just creating medical devices. We’re building a movement.And now, we’re inviting you to be part of it.

Not as a donor.

As an owner.

Impact and Returns - You Don’t Have to Choose

For too long, investors have been told they have to choose: make money, or make a difference.

We’re done with that narrative.

Neopenda is proof that you can have both.Every dollar invested leads to babies monitored, lives saved, systems transformed.

We expect outsized returns, yes, financially. But also in human outcomes.This has an immediate impact with long-term upside.

And let’s be clear: emerging markets are the fastest growing in the world.

Africa is the youngest continent on the planet. These are not “risky frontiers.” These are the future of global growth.

Female Founders, Undervalued (Until They’re Not)

You’ve seen the stat: women still receive less than 2% of venture capital.

You may have even reposted it.

But awareness alone is not enough. We’re inviting you to act.

Invest in a female-founded company that has not only survived but thrived in one of the most complex and capital-constrained sectors of global health.

And if you’re someone who prides yourself on spotting opportunities before the rest of the market catches on, this is your moment.

For the Skeptics

If you’re not sure yet, thank you.

Truly.

We value questions. We welcome critique. And we’re obsessed with getting better.

We’re not asking for blind faith. We’re offering transparency, traction, and tenacity.

But we’re also offering something else: hope.

This Isn’t Charity. It’s a Challenge.

If you believe every mother deserves a safe birth, no matter where she lives…If you believe every baby deserves the chance to grow up healthy, no matter where they’re born…If you believe innovation should reach everyone, not just those in proximity to it…

Invest in Neopenda.

Don’t wait for the headlines.

Be the reason they’re written.

At the root of everything is people.

People like you, who believe in better.

Let’s build this future together.

Join our community round.

Own the story.

Change the system.

And prove that doing good is good business.

Invest now - WeFunder - Neopenda